A crucial element of regenerative healthcare and drug investigation lies in the ability to multiply human stem cell populations to sufficient quantities for therapeutic applications. Traditionally, constrained cell presence posed a significant obstacle to progress in these fields. Consequently, considerable effort has been directed towards optimizi